INE236W01016 ang-lifesciences-india-ltd 'ANG Lifesciences India' '74.20'

ANG Lifesciences India Financial Statement Analysis

ANG Lifesciences India NSE

74.20 00.00 (1.04%) Profit

High
74.63
Low
72.11
Open at
74.63
Prev Close
74.20
Pharmaceuticals

Lightning Fast Investing To view real-time data of ANG Lifesciences India and trade with industry first features, Login or Open Free Demat Account. To view real-time data of ANG Lifesciences India and trade with industry first features, Login or Open Free Demat Account.

Financials:

Revenue, Income Statement, Balance Sheet & Cash Flow

Income Statement

as of March 2022

Financial YearFY 2021-22
All Expenditure (Cr)286.92
Operating Profit (Cr)19.42
EBIDTA (Cr)13.30
Profit Before Tax (Cr)53.50
Tax (Cr)13.19
Net Income (Cr)361.87
EPS (Cr)38.89
DPS (Cr)0.00

Balance Sheet

as of March 2022

Equities & Liabilities

Financial YearFY -
Share Capital (Cr)10.37
Reserves & Surplus (Cr)68.71
Current Liabiltiies (Cr)113.38
Other Liabilities (Cr)18.72
Total Liabilities (Cr)179.49

Assets

Financial YearFY -
Fixed Assets92.61
Current Assets85.55
Other Assets34.16
Total Assets1.29

Cash Flows

as of March 2022

Financial YearFY 2021-22
Operating Activities (Cr)24.72
Investing Activities (Cr)-44.41
Financing Activities (Cr)19.93
Others (Cr)-0.08
Net Cash Flow (Cr)0.23

Frequently Asked Questions on ANG Lifesciences India Share

ANG Lifesciences India latest EBITDA stands at 13.30 for the financial year 2021-22, having previously been 13.302 during -. EBITDA is typically used to measure profitability instead of net income and other factors. You can view EBIDTA and other crucial financial data on Dhan Online Trading App and Web Trading Platform.

ANG Lifesciences India EPS for the latest financial year stood at 38.89 compared to an EPS of - in the previous financial year. View EPS, P/E ratio, and other fundamental data to start investing in stocks on Dhan.

In the latest financial year gone by, ANG Lifesciences India had a net income of 361.87 compared to a net income of - in the year before.

You can use Dhan App and Web to analyze financial statements and trade in . Dhan gives you access to all fundamentals, financials, corporate actions, and much more so that you can make informed trading decisions. Follow these steps to start:

  1. Open free demat account online
  2. Search for ANG Lifesciences India
  3. Select “Fundamentals”
  4. View all the data you need
  5. Start trading


ANG Lifesciences India Financial Statements Overview

ANG Lifesciences India financial statements offers an overview of the company's Revenue, Income Statement, Balance Statement, Cash Flows and more. It helps to analyse the company's financial position and its revenue to profit trend. ANG Lifesciences India reported a Net Income of Rs. 361.87 and an Operating Profit of Rs. 19.42 in the . The Total Liabilities stood at Rs. 179.49 in the last year. The Earning Per Share (EPS) and Dividend Per Share (DPS) stood at Rs. 38.89 and Rs. 0.00 respectively. While, analysing Financial Statements of a company is crucial, it is equally important to look at the Share Price, Stock Performance, Fundamental Analysis, Technicals and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.


Download Dhan App

Ready to Trade & Invest in
ANG Lifesciences India?

Get started in 10 minutes or less from here 👇

+91.


sec_id>